Esketamiini (Finnish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Esketamiini" in Finnish language version.

refsWebsite

Global rank Finnish rank

low place

165^th place

1pharmacafennica.fi

low place

904^th place

447^th place

676^th place

92^nd place

388^th place

4^th place

12^th place

2^nd place

10^th place

5^th place

9^th place

1,226^th place

929^th place

bmj.com

Elisabeth Mahase: Esketamine is approved in Europe for treating resistant major depressive disorder. BMJ, 20.12.2019, nro 367. PubMed:31862692 doi:10.1136/bmj.l7069 ISSN 1756-1833 Artikkelin verkkoversio. (englanti)

doi.org

dx.doi.org

Elisabeth Mahase: Esketamine is approved in Europe for treating resistant major depressive disorder. BMJ, 20.12.2019, nro 367. PubMed:31862692 doi:10.1136/bmj.l7069 ISSN 1756-1833 Artikkelin verkkoversio. (englanti)

fda.gov

Office of the Commissioner: FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor’s office or clinic FDA. 24.3.2020. Viitattu 29.8.2020. (englanniksi)

fimea.fi

spc.fimea.fi

fimea.fi

Lääkehaku: Spravato Fimea. Viitattu 29.8.2020.

nih.gov

pubmed.ncbi.nlm.nih.gov

Elisabeth Mahase: Esketamine is approved in Europe for treating resistant major depressive disorder. BMJ, 20.12.2019, nro 367. PubMed:31862692 doi:10.1136/bmj.l7069 ISSN 1756-1833 Artikkelin verkkoversio. (englanti)

npr.org

FDA Approves A Nasal Spray To Treat Patients Who Are Suicidal NPR.org. Viitattu 29.8.2020. (englanniksi)

pharmacafennica.fi

KETANEST-S injektio-/infuusioneste, liuos 5 mg/ml, 25 mg/ml - Pharmaca Fennica pharmacafennica.fi. Viitattu 29.8.2020.

worldcat.org

Elisabeth Mahase: Esketamine is approved in Europe for treating resistant major depressive disorder. BMJ, 20.12.2019, nro 367. PubMed:31862692 doi:10.1136/bmj.l7069 ISSN 1756-1833 Artikkelin verkkoversio. (englanti)